{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T07:24:35Z","timestamp":1695799475838},"reference-count":0,"publisher":"American Medical Association (AMA)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1001\/journalofethics.2015.17.8.nlit1-1508","type":"journal-article","created":{"date-parts":[[2015,8,21]],"date-time":"2015-08-21T09:04:43Z","timestamp":1440147883000},"page":"750-753","source":"Crossref","is-referenced-by-count":7,"title":["Pricing Cancer Drugs: When Does Pricing Become Profiteering?"],"prefix":"10.1001","volume":"17","member":"10","published-online":{"date-parts":[[2015,8,1]]},"container-title":["AMA Journal of Ethics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journalofethics.ama-assn.org\/article\/pricing-cancer-drugs-when-does-pricing-become-profiteering\/2015-08","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T16:02:31Z","timestamp":1683734551000},"score":1,"resource":{"primary":{"URL":"https:\/\/journalofethics.ama-assn.org\/article\/pricing-cancer-drugs-when-does-pricing-become-profiteering\/2015-08"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,1]]},"references-count":0,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2015,8,1]]}},"alternative-id":["10.1001\/journalofethics.2015.17.8.nlit1-1508"],"URL":"https:\/\/doi.org\/10.1001\/journalofethics.2015.17.8.nlit1-1508","relation":{},"ISSN":["2376-6980"],"issn-type":[{"value":"2376-6980","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,1]]}}}